† Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal 741246, India ‡ Department of Biological Sciences, Indian ...

dadlnet.dk Objective There is a lack of disease-modifying treatments in hypertrophic cardiomyopathy (HCM). The aim of this randomised, placebo-controlled study was to assess if losartan could improve ...

Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients may present with obstructive disease ...

The FDA has approved the drug Camzyos to treat obstructive hypertrophic cardiomyopathy (HCM). A second drug is currently under review. Other medications and lifestyle strategies can also help ...

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The randomized, double-blind, ...

The syndrome, which doctors formally call takotsubo cardiomyopathy, is thought to be triggered by physical or emotional stress, which releases bursts of stress hormones like adrenaline that ...

dilated cardiomyopathy (DCM). Furthermore, the CMR-derived biomarkers of fibrosis (based on ECV) and strain are prognostic for major adverse cardiovascular events (MACE) during the disease's ...

Department of Chemistry, Payame Noor University, PO Box, Tehran 19395-3697, Iran Department of Chemistry and Biochemistry, Chemistry Tech Company, Tehran 19369-34487, Iran ...

These data will be featured in a poster entitled, “A Novel Investigational AAV Gene Therapy for Treatment of BAG3 Dilated Cardiomyopathy,” being presented by Giri Murlidharan, Ph.D., Senior ...